May 2004
Volume 45, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2004
Structural and functional impairment of endocytic pathways by retinitis pigmentosa mutant rhodopsin–arrestin complexes
Author Affiliations & Notes
  • C.–H. Sung
    Ophth Cell Biololoy Anatomy, Weill Med College of Cornell, New York, NY
  • C. Vega
    Ophth Cell Biololoy Anatomy, Weill Med College of Cornell, New York, NY
  • W. Jun
    Ophth Cell Biololoy Anatomy, Weill Med College of Cornell, New York, NY
  • J.–Z. Chuang
    Ophth Cell Biololoy Anatomy, Weill Med College of Cornell, New York, NY
  • Footnotes
    Commercial Relationships  C. Sung, None; C. Vega, None; W. Jun, None; J. Chuang, None.
  • Footnotes
    Support  NIH Grant EY11307, RPB
Investigative Ophthalmology & Visual Science May 2004, Vol.45, 3609. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      C.–H. Sung, C. Vega, W. Jun, J.–Z. Chuang; Structural and functional impairment of endocytic pathways by retinitis pigmentosa mutant rhodopsin–arrestin complexes . Invest. Ophthalmol. Vis. Sci. 2004;45(13):3609.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: Nearly 100 mutations of the rhodopsin gene have been identified in patients with autosomal dominant RP (adRP). Several mutant bovine rhodopsins with amino acid changes at Arg135 have been shown to exhibit higher affinity to rhodopsin kinase and v–arrestin (v–arr) in vitro. There are three known human adRP–associated rhodopsin missense mutations at Arg135 (R135G, R135L, R135W). We examined the interaction between v–arr and Arg135 mutants in transfected HEK cells. The cellular defects caused by Arg135 and v–arr interaction were analyzed both in vitro and in vivo. Methods: Human wild type (wt) or mutant rhodopsins were singly transfected or co–transfected with GFP–v–arr into HEK cells. Transfected cells were examined by immunohistochemistry, biochemical, and endocytosis assays. Expression of mutant rhodopsins in rat retinas was achieved with an in vivo transfection procedure. Results: Although wt rhodopsin predominantly accumulated on the plasma membrane, Arg135 mutant rhodopsin appeared on both the cell surface and on intracellular vesicles of transfected cells. Whole cell phosphorylation experiments suggested that Arg135 mutant is constitutively highly phosphorylated. The Arg135 mutant, but not the wt rhodopsin, was found to be tightly associated with v–arr biochemically. Co–expression experiments suggested that mutant rhodopsin recruited the cytosolic v–arr to the plasma membrane, and that the rhodopsin–arrestin complex was internalized into the endocytic pathway. Furthermore, the rhodopsin–v–arr complexes altered the morphology of endosomal compartments and severely damaged receptor–mediated endocytic functions. Arg135 mutant expression in the transfected rat retinas was employed to corroborate the in vitro results. Conclusions: Arg135 mutations in rhodopsin cause a severe form of RP, consistent with the unique biochemical and cellular defects in these mutant proteins. Because the defects of Arg135 mutant rhodopsins are distinct from those previously described for class I and class II RP mutations, we propose that they be named class III. Impaired endocytic activity may underlie the pathogenesis of RP caused by class III rhodopsin mutations.

Keywords: retinal degenerations: cell biology • proteins encoded by disease genes • opsins 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×